Personal tools
You are here: Home Resources for Health Professionals Research Metformin Extended Release Treatment of Adolescent Obesity

Metformin Extended Release Treatment of Adolescent Obesity

A 48-Week Randomized, Double-Blind, Placebo-Controlled Trial With 48-Week Follow-up. Source: Glaser Pediatric Research Network Obesity Study Group as published in Archives of Pediatrics & Adolescent Medicine, Vol 164, No. 2, February 2010

In this small study (baseline n=77) obese (95th BMI percentile) adolescents (13-18 years of age) were enrolled in a lifestyle intervention program. Participants were randomized to receive a treatment (once daily 2000mg metformin hydrochloride) and to control. After 48 weeks a small change in BMI was noted in the treatment group. No effects of metformin on body composition, abdominal fat of insulin indeces were observed.

 Read article in Archives of Pediatrics & Adolescent Medicine online Journal

 Read abstract of study

 Read full article (pdf)


Document Actions
On this site, you'll find...
...activities, best practices, links and resources for the Washington State Diabetes Network to foster collaboration and communication. From a broad array of organizations and people working in public, private, tribal, community and academic/training sectors to prevent and control diabetes and hypertension among Washington residents.
Learn Your Risk for Prediabetes

Looking for information on Health Transformation in Washington State? Get info on upcoming webinars and the latest news at HealthierWA



 2-1-1 is an easy-to-remember phone number for people to call for health and human service information and referrals and other assistance to meet their needs, including diabetes prevention and management. Dial 2-1-1 or visit